|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/12/2024 |
$3.29 |
$3.31 |
$3.15 |
$3.23 |
354.10K | 04/15/2024 |
$3.25 |
$3.27 |
$3.15 |
$3.18 |
134.50K | 04/16/2024 |
$3.17 |
$3.31 |
$3.13 |
$3.27 |
295.00K | 04/17/2024 |
$3.24 |
$3.31 |
$3.12 |
$3.21 |
95.00K | 04/18/2024 |
$3.19 |
$3.32 |
$3.13 |
$3.25 |
219.40K |
|
ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. | |
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on April 12, 2024, ABIO opened at $3.29, traded as high as $3.31 and as low as $3.15, and closed at $3.23. Trading volume was a total of 354.10K shares. On April 15, 2024, ABIO opened at $3.25, traded as high as $3.27 and as low as $3.15, and closed at $3.18. Trading volume was a total of 134.50K shares. On April 16, 2024, ABIO opened at $3.17, traded as high as $3.31 and as low as $3.13, and closed at $3.27. Trading volume was a total of 295.00K shares. On April 17, 2024, ABIO opened at $3.24, traded as high as $3.31 and as low as $3.12, and closed at $3.21. Trading volume was a total of 95.00K shares. On April 18, 2024, ABIO opened at $3.19, traded as high as $3.32 and as low as $3.13, and closed at $3.25. Trading volume was a total of 219.40K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$217.98 |
|
End price/share: |
$3.25 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.51% |
|
Average Annual Total Return: |
-34.34% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$149.11 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/12/2024 | $3.23 | 04/15/2024 | $3.18 | 04/16/2024 | $3.27 | 04/17/2024 | $3.21 | 04/18/2024 | $3.25 |
|
|